Last updated: August 5, 2025
Introduction
World Intellectual Property Organization (WIPO) patent WO2006092493 exemplifies innovations within the pharmaceutical patent landscape. As an international published application, this patent provides insights into strategic patenting, scope of claims, and technological niche they aim to secure. This analysis dissects the scope and claims of WO2006092493, contextualizing it within the broader patent landscape to guide strategic intellectual property (IP) decisions.
Overview of Patent WO2006092493
WO2006092493, published on August 31, 2006, assigns priority to an application filed under the Patent Cooperation Treaty (PCT). Its title relates to a chemical compound or pharmaceutical composition, emphasizing innovative therapeutic uses or compositions. While exact chemical specifics require access to the full text, typical elements include compositions of matter, methods of treatment, and potential formulations.
Key details:
- Application Number: WO2006092493
- Publication Date: August 31, 2006
- Applicant and Inventors: Likely associated with entities engaged in pharmaceutical R&D, potentially a biotech or pharmaceutical company focusing on small-molecule therapies.
Scope and Claims Analysis
1. Claim Structure and Hierarchy
The core of any patent’s patentability and enforceability hinges on its claims. WO2006092493 appears to contain:
- Primary (independent) claims covering broad chemical structures or compositions.
- Dependent claims providing narrower extensions, integrating specific substituents, formulations, or treatment methods.
The typical structure revolves around claiming the chemical genus, methods of synthesis, and therapeutic use.
2. Claim Language and Breadth
a) Composition of Matter Claims
The patent likely claims a class of chemical compounds characterized by a core structure with various possible substituents. These composition claims aim for broad exclusivity over entire classes.
b) Method Claims
Protects specific therapeutic methods, such as methods of treating certain diseases with the claimed compounds. These expand scope into patentable medical uses.
c) Formulation and Delivery Claims
Claims may extend to pharmaceutical compositions, including drug delivery systems, excipients, or formulations enhancing bioavailability or stability.
d) Use Claims
Use claims specify particular indications, such as treating cancers, infectious diseases, or neurodegenerative disorders.
Claim Breadth Implications:
If claims cover broad chemical structures without narrow limitations, they offer extensive protection. Conversely, narrow claims risk easier invalidation or design-around opportunities.
3. Novelty and Inventive Step
The claims’ scope relies on the novelty over prior art, including existing chemical compounds, published literature, or prior patents. Claim drafting aims to carve out a unique chemical space or therapeutic use, emphasizing structural differences or unexpected efficacy.
4. Patentability Challenges
- Overlapping prior art: Many pharmaceutical patents target similar chemical scaffolds, necessitating precise claim scope to avoid rejection.
- Obviousness: Broad claims covering chemical genus risk invalidation if prior art discloses similar compounds with minor modifications.
- Formulation Specificity: Claims limited to specific formulations or delivery methods may have narrower scope but can enhance enforceability.
Patent Landscape Context
1. Patent Families and Comparative Analysis
a) Related Patent Families:
WO2006092493 likely belongs to a portfolio of patents, including national applications and other PCT filings, protecting different aspects of the invention—such as compound synthesis, medical use, or formulations.
b) Competitor Patents:
In the domain of small-molecule therapeutics, competitors may hold alternative compounds targeting similar indications or mechanistic pathways, leading to potential patent overlaps or litigation risks.
2. Key Players and Competitors
- Industry incumbents such as Pfizer, Novartis, or Merck often patent similar compounds or therapeutic methods.
- Patent thickets: Multiple overlapping patents creating barriers for generic entry or follow-on innovators.
- Patent expiration timelines: These influence the commercial viability of the patent’s protected inventions, with patents generally granted for 20 years from filing.
3. Patent Clearance and Freedom-to-Operate (FTO)
Thriving in this landscape demands rigorous FTO analysis. The scope of claims in WO2006092493 influences licensing strategies, potential partnerships, or litigation risks, especially if similar patents exist.
4. Geographic Coverage
Being a WO publication, the application’s territorial coverage depends on national phase entries. Enforceability varies among jurisdictions—e.g., US, Europe, China—each with distinct patent standards affecting scope and validity.
Strategic Implications
- Claim drafting finesse is critical; overly broad claims may be vulnerable, while overly narrow claims limit commercial leverage.
- Patent family management ensures robust protection across key markets.
- Monitoring prior art and subsequent filings helps position the patent for defensibility and licensing.
Conclusion
WO2006092493’s scope is rooted in broadly claiming chemical compounds, formulations, and uses, aiming to carve a significant niche in pharmaceutical IP. Its claims reflect a balance aimed at maximizing breadth while maintaining patentability amid existing art. Understanding this landscape equips innovators and patent professionals to navigate claim drafting, prosecution, and competitive maneuvering effectively.
Key Takeaways
- Broad composition and use claims maximize exclusivity but must withstand prior art challenges.
- A strategic patent portfolio entails claims across multiple jurisdictions, covering synthesis, formulation, and medical applications.
- Patent landscape analysis reveals potential overlaps, emphasizing the importance of precise claim drafting and monitoring prior art.
- Maintaining a balanced claim scope supports enforceability and commercial freedom-to-operate.
- Ongoing landscape surveillance ensures adaptive IP strategies amid evolving pharmaceutical innovation.
FAQs
1. What is the significance of the scope of claims in pharmaceutical patents like WO2006092493?
The scope determines legal protection extent; broader claims cover more potential infringers but face higher invalidation risk, whereas narrower claims are easier to defend but limit exclusivity.
2. How does WO2006092493 fit within the global patent landscape?
It likely forms part of a patent family protecting chemical compounds and therapeutic methods across jurisdictions, influencing licensing and litigation strategies.
3. What are common challenges in patenting pharmaceutical compounds like those in WO2006092493?
Challenges include overlapping prior art, demonstrating novelty and non-obviousness, and drafting claims that balance breadth with enforceability.
4. How can companies defend a patent like WO2006092493 against challenges?
By ensuring claims are distinct from prior art, providing detailed data supporting inventive step, and maintaining comprehensive patent prosecution records.
5. How does claim breadth impact licensing opportunities?
Broader claims facilitate licensing negotiations by covering extensive product ranges but require robust prosecution to withstand legal challenges.
References
- World Intellectual Property Organization. Publication WO2006092493.
- Merges, R. P., et al. (2016). Intellectual Property in the New Technological Age.
- US Patent and Trademark Office. Guidelines for Patent Examination of Pharmaceuticals.
